⌘K
Loading ticker…
Genprex, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Genprex, Inc. Common Stock (GNPX) has a 3-month relative strength percentile of 2 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 23. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 10.4%, relative volume 0.51×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
2 is not yet a leadership-grade RS read, Market Stance is 47
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
GNPX is in a stage 4 downtrend, week 12. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -37.6% / -87.1%.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
GNPX appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $11K notional.
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $11K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GNPX Jan avg: 2.16% median: -8.01% win: 50% σ: 35.30% n: 4 2022-04-12 → 2026-05-29 | GNPX Feb avg: -30.05% median: -31.93% win: 0% σ: 13.91% n: 4 2022-04-12 → 2026-05-29 | GNPX Mar avg: -26.01% median: -29.81% win: 0% σ: 11.29% n: 4 2022-04-12 → 2026-05-29 | GNPX Apr avg: -16.53% median: -20.79% win: 20% σ: 23.43% n: 5 2022-04-12 → 2026-05-29 | GNPX May avg: 5.84% median: 5.28% win: 60% σ: 21.92% n: 5 2022-04-12 → 2026-05-29 | GNPX Jun avg: -16.60% median: -18.58% win: 25% σ: 23.01% n: 4 2022-04-12 → 2026-05-29 (current) | GNPX Jul avg: -7.35% median: -5.44% win: 50% σ: 9.99% n: 4 2022-04-12 → 2026-05-29 | GNPX Aug avg: -26.19% median: -30.31% win: 25% σ: 30.74% n: 4 2022-04-12 → 2026-05-29 | GNPX Sep avg: -19.95% median: -17.94% win: 25% σ: 21.32% n: 4 2022-04-12 → 2026-05-29 | GNPX Oct avg: 110.65% median: -17.71% win: 25% σ: 274.80% n: 4 2022-04-12 → 2026-05-29 | GNPX Nov avg: -22.87% median: -24.72% win: 25% σ: 31.77% n: 4 2022-04-12 → 2026-05-29 | GNPX Dec avg: -15.07% median: -13.41% win: 25% σ: 20.97% n: 4 2022-04-12 → 2026-05-29 |